Key Data Elements for Use in Cost-Utility Modeling of Biological Treatments for Rheumatoid Arthritis.
Severe hypoglycemia rates and associated costs among type 2 diabetics starting basal insulin therapy in the United States.
Clinical effectiveness of liraglutide across body mass index in patients with type 2 diabetes in the United States: a retrospective cohort study.
Clinical and economic outcomes associated with blood transfusions among elderly Americans following coronary artery bypass graft surgery requiring cardiopulmonary bypass.
The association of body mass index with the risk of type 2 diabetes: a case-control study nested in an electronic health records system in the United States.
The cost-effectiveness of the levonorgestrel-releasing intrauterine system for the treatment of idiopathic heavy menstrual bleeding in the United States.
The contextual effects of social capital on health: a cross-national instrumental variable analysis.
Modeling the social determinants of caregiver burden among families of children with developmental disabilities.
Social determinants of state variation in special education participation among preschoolers with developmental delays and disabilities.
Revisiting the association between maternal smoking during pregnancy and ADHD.
Economic costs of overactive bladder in the United States.
The impact of the public insurance expansions on children's use of preventive dental care.
Medicare payments, healthcare service use, and telemedicine implementation costs in a randomized trial comparing telemedicine case management with usual care in medically underserved participants with diabetes mellitus (IDEATel).
The effect of state early intervention eligibility policy on participation among a cohort of young CSHCN.
The financial implications of availability and quality of a usual source of care for children with special health care needs.
Intimate partner violence exposure and change in women's physical symptoms over time.
Patterns of eye care use and expenditures among children with diagnosed eye conditions.
Abused women disclose partner interference with health care: an unrecognized form of battering.
The lifetime distribution of the incremental societal costs of autism.
Prevalence and correlates of children's diagnosed eye and vision conditions.
Community preferences for health states associated with intimate partner violence.
Mental health care services for children with special health care needs and their family members: prevalence and correlates of unmet needs.
Assessing intimate partner violence in health care settings leads to women's receipt of interventions and improved health.
Continuity of health insurance coverage for children with special health care needs.
Intimate partner violence and patient screening across medical specialties.
Adverse health behaviors and the detection of partner violence by clinicians.
The Pediatric Alliance for Coordinated Care: evaluation of a medical home model.
The economic evaluation of obesity interventions: its time has come.
The doctor's dilemma: challenges for the primary care physician caring for the child with special health care needs.
Family health effects: complements or substitutes.
Evaluation of Medicaid managed care for children: access and satisfaction.
The relationship between external threats and smoking in central Harlem.
Risk factors for excess mortality in Harlem. Findings from the Harlem Household Survey.
Region of birth and black diets: the Harlem Household Survey.
Laying down the law: reducing illegal tobacco sales to minors in central Harlem.
Contribution of smoking to excess mortality in Harlem.
Social epidemiology and the fundamental cause concept: on the structuring of effective cancer screens by socioeconomic status.
Acceptance and use of Put Prevention into practice materials at an inner-city hospital.
Putting prevention into practice. Impact of a multifaceted physician education program on preventive services in the inner city.
Real-world clinical effectiveness of liraglutide in individuals 65 years and older with type 2 diabetes in the United States
Comparative real world effectiveness of liraglutide versus sitagliptin in patients with type 2 diabetes as an add-on to metformin monotherapy in the United States